• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

    26.16 -0.72 (-2.68%)
    Streaming Delayed Price Updated: 3:42 PM EDT, Aug 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 500,901
    Open 26.52
    Bid (Size) 26.15 (200)
    Ask (Size) 26.18 (700)
    Prev. Close 26.88
    Today's Range 26.16 - 26.87
    52wk Range 8.195 - 28.23
    Shares Outstanding 47,147,781
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    From Nurix Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
    href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell... 
    Via Benzinga
    Topics Stocks

    Performance

    YTD
    +44.9%
    +44.9%
    1 Month
    +8.3%
    +8.3%
    3 Month
    +48.0%
    +48.0%
    6 Month
    +62.4%
    +62.4%
    1 Year
    +173.9%
    +173.9%

    More News

    Read More
    News headline image
    A Nurix Therapeutics (NRIX) Insider Sold 5,394 Shares for $90,000 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Nurix Therapeutics Inc (NASDAQ:NRIX) Reports Mixed Q4 2025 Results, Highlights Key Clinical Milestone ↗
    Via Chartmill
    Nurix Stock Falls After-Hours After Wider Q3 Loss; Oppenheimer Sees FDA Support For Bexo, Retail Buys The Dip ↗
    Via Stocktwits
    News headline image
    Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
    From Nurix Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
    From Nurix Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million ↗
    Via The Motley Fool
    News headline image
    Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
    Via Chartmill
    News headline image
    Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
    From Equity Insider
    Via GlobeNewswire
    News headline image
    13 Analysts Have This To Say About Nurix Therapeutics ↗
    Via Benzinga
    News headline image
    Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
    Via MarketMinute
    News headline image
    Breaking Down Nurix Therapeutics: 5 Analysts Share Their Views ↗
    Via Benzinga
    News headline image
    Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday ↗
    Via Benzinga
    News headline image
    NURIX THERAPEUTICS INC (NASDAQ:NRIX) Misses Q3 2025 Estimates, Shares Drop ↗
    Via Chartmill
    News headline image
    6 Analysts Assess Nurix Therapeutics: What You Need To Know ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Which stocks are moving after the closing bell on Thursday? ↗
    Via Chartmill
    News headline image
    A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts ↗
    Via Benzinga

    Frequently Asked Questions

    Is Nurix Therapeutics, Inc. - Common stock publicly traded?
    Yes, Nurix Therapeutics, Inc. - Common stock is publicly traded.
    What exchange does Nurix Therapeutics, Inc. - Common stock trade on?
    Nurix Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Nurix Therapeutics, Inc. - Common stock?
    The ticker symbol for Nurix Therapeutics, Inc. - Common stock is NRIX on the Nasdaq Stock Market
    What is the current price of Nurix Therapeutics, Inc. - Common stock?
    The current price of Nurix Therapeutics, Inc. - Common stock is 26.16
    When was Nurix Therapeutics, Inc. - Common stock last traded?
    The last trade of Nurix Therapeutics, Inc. - Common stock was at 08/28/26 03:42 PM ET
    What is the market capitalization of Nurix Therapeutics, Inc. - Common stock?
    The market capitalization of Nurix Therapeutics, Inc. - Common stock is 1.23B
    How many shares of Nurix Therapeutics, Inc. - Common stock are outstanding?
    Nurix Therapeutics, Inc. - Common stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.